PRPO
Precipio, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$26.62
+1.92%Aug 14, 2026, 20:00 UTC
Precipio reported Q2 2026 financial results, achieving record quarterly revenue, returning to positive Adjusted EBITDA, and strengthening its cash position.